Objective To assess AIDS stigmatising attitudes and behaviours by prevention of mother-to-child transmission (PMTCT) service providers in primary healthcare centres in Lagos, Nigeria. Design ...

There are several forms of prevention to be considered: primary, secondary and tertiary. Tertiary prevention is what we undertake in our clinical practises. We attempt to modify factors which ...

It's the world's first twice-yearly shot and was shown in trials to be 96% effective at preventing HIV. Advocates call it a gamechanger. Doctors Detected a Mysterious Antibody in a French Woman's ...

Soon after that, the Trump administration decimated the nation’s domestic HIV prevention programs amid Robert F. Kennedy Jr.’s dramatic takeover of the Department of Health and Human Services. Kennedy ...

A drug with the potential to drastically curb the HIV epidemic just cleared its first regulatory hurdle. On Wednesday, the Food and Drug Administration approved lenacapavir for the prevention of HIV.

“What could be an extraordinary game changer for HIV prevention is being completely undermined by Gilead’s greed. Charging $28,218 a year will drastically limit the availability of the drug.

5. Kelley CF, Acevedo-Quiñones M, Agwu AL, et al. Twice-yearly lenacapavir for HIV prevention in men and gender-diverse persons. N Engl J Med. 2025;392:1261-1276 doi:10.1056/NEJMoa2411858 6.

The FDA on Wednesday approved a highly effective long-acting shot for HIV prevention that is administered just twice per year, greatly extending the time people can go between doses of a ...

Soon after that, the Trump administration decimated the nation’s domestic HIV prevention programs amid Robert F. Kennedy Jr.’s dramatic takeover of the Department of Health and Human Services.

Key messages The employment use of primary-level and community workers may improve the mental health of adults and children living in low- and middle-income countries. However, more evidence is needed ...

FA new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month. If approved, the shot—lenacapavir—would be given twice a year and ...